These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 29441457)
1. Effect of VSL#3 Probiotic in a Patient with Glycogen Storage Disease Type Ia and Irritable Bowel Disease-like Disease. Carnero-Gregorio M; Molares-Vila A; Corbalán-Rivas A; Villaverde-Taboada C; Rodríguez-Cerdeira C Probiotics Antimicrob Proteins; 2019 Mar; 11(1):143-149. PubMed ID: 29441457 [TBL] [Abstract][Full Text] [Related]
2. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Guandalini S; Cernat E; Moscoso D Benef Microbes; 2015; 6(2):209-17. PubMed ID: 25391345 [TBL] [Abstract][Full Text] [Related]
3. Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Dale HF; Rasmussen SH; Asiller ÖÖ; Lied GA Nutrients; 2019 Sep; 11(9):. PubMed ID: 31480656 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial. Han K; Wang J; Seo JG; Kim H J Gastroenterol; 2017 Apr; 52(4):432-443. PubMed ID: 27178566 [TBL] [Abstract][Full Text] [Related]
5. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Harris LA; Baffy N Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910 [TBL] [Abstract][Full Text] [Related]
6. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review. Moraes-Filho JP; Quigley EM Arq Gastroenterol; 2015 Dec; 52(4):331-8. PubMed ID: 26840477 [TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Kim HJ; Vazquez Roque MI; Camilleri M; Stephens D; Burton DD; Baxter K; Thomforde G; Zinsmeister AR Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307 [TBL] [Abstract][Full Text] [Related]
8. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial. Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935 [TBL] [Abstract][Full Text] [Related]
9. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933 [TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Kim HJ; Camilleri M; McKinzie S; Lempke MB; Burton DD; Thomforde GM; Zinsmeister AR Aliment Pharmacol Ther; 2003 Apr; 17(7):895-904. PubMed ID: 12656692 [TBL] [Abstract][Full Text] [Related]
11. Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. Haller D; Antoine JM; Bengmark S; Enck P; Rijkers GT; Lenoir-Wijnkoop I J Nutr; 2010 Mar; 140(3):690S-7S. PubMed ID: 20107148 [TBL] [Abstract][Full Text] [Related]
12. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240 [TBL] [Abstract][Full Text] [Related]
13. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Whelan K; Quigley EM Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925 [TBL] [Abstract][Full Text] [Related]
14. Diet therapy for inflammatory bowel diseases: The established and the new. Durchschein F; Petritsch W; Hammer HF World J Gastroenterol; 2016 Feb; 22(7):2179-94. PubMed ID: 26900283 [TBL] [Abstract][Full Text] [Related]
15. Probiotics in functional bowel disorders. Hod K; Ringel Y Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):89-97. PubMed ID: 27048900 [TBL] [Abstract][Full Text] [Related]
16. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. Ganji-Arjenaki M; Rafieian-Kopaei M J Cell Physiol; 2018 Mar; 233(3):2091-2103. PubMed ID: 28294322 [TBL] [Abstract][Full Text] [Related]
17. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome. Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486 [TBL] [Abstract][Full Text] [Related]
18. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial. Yılmaz İ; Dolar ME; Özpınar H Turk J Gastroenterol; 2019 Mar; 30(3):242-253. PubMed ID: 30662004 [TBL] [Abstract][Full Text] [Related]
19. [Irritable Bowel Syndrome; gut microbiota and probiotic therapy]. Tojo González R; Suarez Gonzalez A; Rúas Madiedo P; Mancebo Mata A; Pipa Muñiz M; Barreiro Alonso E; Roman Llorente FJ; Moro Villar MC; Arce González MM; Villegas Diaz MF; Mosquera Sierra E; Ruiz Ruiz M Nutr Hosp; 2015 Feb; 31 Suppl 1():83-8. PubMed ID: 25659060 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered. Qiao YQ; Cai CW; Ran ZH J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]